# FDA 483 - District Hospital Partners LP - November 25, 2024

Source: https://www.globalkeysolutions.net/records/483/district-hospital-partners-lp/6da3770e-0643-4b53-8751-0ba3c44c61d1

> FDA 483 for District Hospital Partners LP on November 25, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: District Hospital Partners LP
- Inspection Date: 2024-11-25
- Product Type: biologics
- Office Name: Baltimore District Office
- Summary: An FDA inspection of District Hospital Partners LP (George Washington University Hospital) identified significant deficiencies in their Hospital Blood Bank/Transfusion Services. Observations included failures to maintain complete records for emergency blood transfusions, specifically lacking physician signatures or justifications. Additionally, the facility failed to concurrently document critical steps in the processing of blood and blood components, impacting traceability.

## Related Officers

- [FDA_PERSONNEL](https://www.globalkeysolutions.net/people/chanel-e-crawford/9bad6899-4c17-405f-babb-554cee8d09e7)
- [La-tasha M. Gunter](https://www.globalkeysolutions.net/people/la-tasha-m-gunter/db9cd9cf-db0a-4c31-9f7c-24760750f34d)

Company: https://www.globalkeysolutions.net/companies/district-hospital-partners-lp/bae4eec2-2020-4e6b-aea4-850bb197c9fa

Office: https://www.globalkeysolutions.net/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa